New Zealand Coastal Seafoods Limited announced that the Company has entered a Toll Processing agreement with Bio-Mer Limited ("Bio-Mer"), with Bio-Mer to provide the extraction capability and processing required to produce NZCS's marine collagen product at scale ("Agreement"). As previously announced, the Company has been building a business case for specialised manufacturing equipment, whilst concurrently building strong demand for output products. With access to high quality extraction equipment forming a critical step in the commercialisation process, the Agreement will significantly reduce the capital expenditure required to produce marine collagen powder and other powdered nutraceutical products at scale, with market entry into the marine collagen market being expedited. The alliance, in addition to the Agreement for collagen extraction, will allow the Company to extract additional value from other marine products, including the valuable EU compliant mussel oil. Further under the alliance, the parties will work together in co-marketing products including Bio- Mer's premium anti-inflammatory & nootropic /cognitive function enhancement product "Tripernol Plus" to the consumer market. The Agreement aligns with the Company's strategy of improving profit margins by extending NZCS's range of products. The Agreement will run for a term of 2 years, with the option for NZCS to extend for a further two years. The Agreement may be terminated by either party giving six months notice and otherwise contains termination clauses common for agreements of this nature.